Service primary cell culture2022-07-18T08:06:15+00:00

Services

primary cell culture

With more that 25 years of experience in human tissue disaggregation and selection of specific cell types, Evercyte offers services to establish human primary cell cultures from various tissues and organs. The studies are performed with ethical approval from the local ethical committee and prior given written informed consent by the donor.

Related Services

life span extension of human normal cells while maintaining cell type specific markers and functions

BM-MSC/TERT292

Bone marrow - derived mesenchymal stem cells

MSCs for production of clinical grade extracellular vesicles

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

"Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed."

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

all about our
EV cell factories

Related Products

human primary-like cells from different tissues

Related Services

life span extension of human normal cells while maintaining cell type specific markers and functions

Mesenchymal stromal cells (MSCs) for production of clinical grade extracellular vesicles / exosomes

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

"Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed."

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

Go to Top